Prelude Capital Management’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-34,136
| Closed | -$810K | – | 1478 |
|
|
2023
Q3 | $810K | Buy |
+34,136
| New | +$642K | 0.05% | 345 |
|
|
2022
Q2 | – | Sell |
-28,501
| Closed | -$596K | – | 2164 |
|
|
2022
Q1 | $596K | Sell |
28,501
-196
| -0.7% | -$3.75K | 0.02% | 784 |
|
|
2021
Q4 | $511K | Sell |
28,697
-819
| -3% | -$13.2K | 0.01% | 989 |
|
|
2021
Q3 | $416K | Buy |
+29,516
| New | +$459K | 0.01% | 990 |
|
|
2020
Q4 | – | Sell |
-2,275
| Closed | -$29K | – | 2150 |
|
|
2020
Q3 | $29K | Buy |
2,275
+169
| +8% | +$2.16K | ﹤0.01% | 1266 |
|
|
2020
Q2 | $23K | Sell |
2,106
-367
| -15% | -$3.8K | ﹤0.01% | 1355 |
|
|
2020
Q1 | $26K | Sell |
2,473
-5,402
| -69% | -$69.7K | ﹤0.01% | 924 |
|
|
2019
Q4 | $127K | Buy |
7,875
+2,475
| +46% | +$40.9K | ﹤0.01% | 1011 |
|
|
2019
Q3 | $85K | Buy |
+5,400
| New | +$89.8K | ﹤0.01% | 1006 |
|
|
2019
Q2 | – | Sell |
-454
| Closed | -$8K | – | 2247 |
|
|
2019
Q1 | $8K | Hold |
454
| – | – | ﹤0.01% | 1561 |
|
|
2018
Q4 | $7K | Buy |
+454
| New | +$7.79K | ﹤0.01% | 1491 |
|
|
2018
Q3 | – | Sell |
-3,586
| Closed | -$70K | – | 2125 |
|
|
2018
Q2 | $70K | Sell |
3,586
-10,731
| -75% | -$170K | ﹤0.01% | 1037 |
|
|
2018
Q1 | $195K | Buy |
14,317
+6,714
| +88% | +$88.5K | 0.01% | 687 |
|
|
2017
Q4 | $103K | Sell |
7,603
-6,033
| -44% | -$86.6K | 0.01% | 781 |
|
|
2017
Q3 | $214K | Buy |
13,636
+11,164
| +452% | +$180K | 0.02% | 626 |
|
|
2017
Q2 | $43K | Sell |
2,472
-13,676
| -85% | -$208K | ﹤0.01% | 1053 |
|
|
2017
Q1 | $246K | Sell |
16,148
-27,953
| -63% | -$412K | 0.02% | 493 |
|
|
2016
Q4 | $580K | Buy |
44,101
+14,383
| +48% | +$184K | 0.07% | 298 |
|
|
2016
Q3 | $336K | Sell |
29,718
-3,400
| -10% | -$40.8K | 0.04% | 401 |
|
|
2016
Q2 | $394K | Buy |
33,118
+15,091
| +84% | +$203K | 0.06% | 330 |
|
|
2016
Q1 | $275K | Buy |
18,027
+8,949
| +99% | +$136K | 0.04% | 438 |
|
|
2015
Q4 | $146K | Buy |
9,078
+1,178
| +15% | +$17.2K | 0.02% | 673 |
|
|
2015
Q3 | $99K | Sell |
7,900
-1,300
| -14% | -$17.8K | 0.01% | 842 |
|
|
2015
Q2 | $152K | Sell |
9,200
-2,700
| -23% | -$43.5K | 0.02% | 740 |
|
|
2015
Q1 | $190K | Buy |
11,900
+5,100
| +75% | +$84.3K | 0.03% | 675 |
|
|
2014
Q4 | $106K | Hold |
6,800
| – | – | 0.02% | 981 |
|
|
2014
Q3 | $94K | Buy |
6,800
+2,400
| +55% | +$36.4K | 0.01% | 1115 |
|
|
2014
Q2 | $71K | Buy |
+4,400
| New | +$69.6K | 0.01% | 1243 |
|
Other funds holding NXGN
Prelude Capital Management's NXGN Position: Q4 2023 in Review
Prelude Capital Management sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 34,136 shares — an estimated $810K sold.
Prelude Capital Management first reported a position in NXGN in Q2 2014 and held it in 28 quarters. The position peaked at $810K in Q3 2023. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.
- Prelude Capital Management reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Prelude Capital Management sold 34,136 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $810K.
- Prelude Capital Management first reported a position in NextGen Healthcare, Inc. Common Stock in Q2 2014 and held it in 28 quarters.
- Prelude Capital Management's NextGen Healthcare, Inc. Common Stock position peaked at $810K in Q3 2023.
- 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.
Based on Prelude Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.